Ilyas Singec

Dr. Ilyas Singeç has a broad scientific background gained in academia, industry, and government. In his most recent role he was the Chief Scientific Officer of FUJIFILM Cellular Dynamics, a global developer and manufacturer of human cells derived from induced pluripotent stem cells (iPSCs). Prior to this role, he served as the inaugural director of the Stem Cell Translation Laboratory (SCTL) at the National Institutes of Health (NIH). The SCTL was funded by the NIH Common Fund (Office of the NIH Director) with the mission to help advance the iPSC technology into clinical applications and drug discovery by developing innovative foundational technologies that can be broadly utilized. At NIH, he introduced novel methods for iPSC culture, single-cell cloning, and genome editing. He also pioneered industrial-scale robotic cell culture and the development of advanced cell differentiation protocols. Prior to this role, Dr. Singeç held leadership positions at Pfizer and the Sanford-Burnham-P